Skip to main content
C. David Hansen
( out of 457 reviews )

C. David Hansen, MD

Languages spoken: English, German

Clinical Locations

Midvalley Health Center

Murray
801-581-2955
  • C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

    Board Certification

    American Board of Dermatology (Dermatology)

    Patient Rating

    5.0 /5
    ( out of 457 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    April 27, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I recommend gentle, caring opportunity with Dr. Hansen and assistants.

    April 26, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    thanks for great care

    April 25, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Best Doc in the whole State¿..maybe the whole world. I¿m a lifetime patient, mine or his.

    April 24, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen is the best and he can never retire.

    April 24, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen is the best!

    April 21, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Wonderful person and doctor

    April 17, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I have been seeing Dr. Hansen for years and he is always amazing.

    April 17, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    One of the most professional physicians I've ever seen for care!

    April 12, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr. Hansen is an exceptional and caring doctor.

  • C. David Hansen, M.D., is a dermatologist with a practice focused on the treatment of general dermatology. He has a particular emphasis in the management of acne, eczema, psoriasis, and skin cancer. After 20 years in private practice, Dr. Hansen joined the University of Utah School of Medicine faculty full-time in 1998. His research interests are in genetic skin disorders including Pachyonychia congenita. He is board certified in dermatology.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    American Board of Dermatology (Dermatology)

    Education history

    Postdoctoral Training Dermatology - Massachusetts General Hospital Postdoctoral Training
    Dermatology - University of Michigan Resident
    Internship University of Iowa Hospitals and Clinics Intern
    Medicine - University of Utah Hospital School of Medicine M.D.
    Undergraduate Chemistry - University of Utah B.S.
    Undergraduate Chemistry - University of Utah

    Selected Publications

    Journal Article

    1. Schwartz JN, Evans HA, Otoole EA, Hansen CD (2023). Pachyonychia Congenita Project: Advancing Research and Drug Development through Collaboration. Keio J Med. (Read full article)
    2. Lipner SR, Falotico JM, Matushansky JT, Evans H, Schwartz J, Hansen CD (2022). Walking a day in a pachyonychia congenita patient's shoes: Impact on plantar pain and activity levels measured with wristband activity trackers. Indian J Dermatol Venereol Leprol, 89(6), 850-853. (Read full article)
    3. Tan XL, Thomas BR, Steele L, Schwartz J, Hansen CD, OToole EA (2022). Genotype-phenotype correlations of neurovascular structures on the feet in patients with pachyonychia congenita: A cross-sectional study. J Am Acad Dermatol. (Read full article)
    4. Mathews J, Hansen CD, Chandrashekar L (2020). Homozygous dominant missense mutation in Keratin 6b leading to severe pachyonychia congenita. Clin Exp Dermatol, 46(2), 410-412. (Read full article)
    5. Samuelov L, Sarig O, Adir N, Pavlovsky M, Smith FJ, Schwartz J, Hansen CD, Sprecher E (2021). Identification of clinically useful predictive genetic variants in pachyonychia congenita. Clin Exp Dermatol, 46, 867-873. (Read full article)
    6. Stewart CL, Takeshita J, Hansen CD, Rubin AI (2020). The histopathological features of the nail plate in pachyonychia congenita. J Cutan Pathol, 47(4), 357-362. (Read full article)
    7. Goldberg I, Mashiah J, Kutz A, Derowe A, Warshauer E, Schwartz ME, Smith F, Sprecher E, Hansen CD (2019). Symptomatic mucosal involvement in pachyonychia congenita: challenges in infants and young children. Br J Dermatol, 182(3), 708-713. (Read full article)
    8. Samuelov L, Smith FJD, Hansen CD, Sprecher E (2020). Revisiting pachyonychia congenita: a case-cohort study of 815 patients. Br J Dermatol, 182(3), 738-746. (Read full article)
    9. Han M, Wald I, Usher W, Wu Q, Wang F, Pascucci V, Hansen CD, Johnson CR (2019). Ray Tracing Generalized Tube Primitives: Method and Applications. Eurographics Workshop Vis Comput Biomed, 38(3), 467-478. (Read full article)
    10. Eliason MJ, Leachman SA, Feng BJ, Schwartz ME, Hansen CD (2012). A review of the clinical phenotype of 254 patients with genetically confirmed pachyonychia congenita. J Am Acad Dermatol, 67(4), 680-6. (Read full article)
    11. Wilson NJ, Leachman SA, Hansen CD, McMullan AC, Milstone LM, Schwartz ME, McLean WH, Hull PR, Smith FJ (2011). A large mutational study in pachyonychia congenita. J Invest Dermatol, 131(5), 1018-24. (Read full article)
    12. Leachman SA, Hickerson RP, Schwartz ME, Bullough EE, Hutcherson SL, Boucher KM, Hansen CD, Eliason MJ, Srivatsa GS, Kornbrust DJ, Smith FJ, McLean WI, Milstone LM, Kaspar RL (2010). First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther, 18(2), 442-6. (Read full article)
    13. Hansen CD (1994). Advances in the Treatment of Onychomycosis. 1-3.

    Letter

    1. Steele L, Schwartz J, Hansen CD, OToole EA (2022). Prevalence and Characterization of Itch in Pachyonychia Congenita. [Letter to the editor]. JAMA Dermatol, 157(11), 1378-1380. (Read full article)
    2. Funk T, Hansen CD, Paller A, OToole EA (2019). Update on pachyonychia congenita research. [Letter to the editor]. Br J Dermatol, 182(3), 788-789. (Read full article)
    3. Wilson NJ, Prez ML, Vahlquist A, Schwartz ME, Hansen CD, McLean WH, Smith FJ (2012). Homozygous dominant missense mutation in keratin 17 leads to alopecia in addition to severe pachyonychia congenita. [Letter to the editor]. J Invest Dermatol, 132(7), 1921-4. (Read full article)